Informa
Antibody Engineering & Therapeutics US
2024年12月15-18日
美國加州聖地牙哥, Marriott Marquis San Diego Marina 以面對面形式舉行: 2024年12月15-18日

PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)

PRE-CONFERENCE WORKSHOPS (pm only) and TRAINING COURSE (full day - PT (Pacific Time, GMT-08:00)

8:00am - 9:00am60 mins
Training Course Registration
    OPTIONAL PRE-CONFERENCE TRAINING COURSE 9:00 am - 5:00 pm -and PRE-CONFERENCE WORKSHOPS 1:00 PM - 5:00 PM
    9:00am - 5:00pm480 mins
    Training Course: Introduction to Antibody Engineering
    Introduction to Antibody Engineering
    • David Bramhill, PhD - Consultant, Bramhill Biological Consulting, LLC
    10:00am - 10:10am10 mins
    Early Career Scientist Session
    Early Career Scientist Session Welcome and Opening Remarks
      10:10am - 10:25am15 mins
      Early Career Scientist Session
      Early Career Scientist Presentation #1: Design Meets Biology - Engineering Next Generation Immune Engagers
      • John Schardt, PhD - Senior Scientist, AstraZeneca
      10:25am - 10:40am15 mins
      Early Career Scientist Session
      Early Career Scientist Presentation #2
        10:40am - 10:55am15 mins
        Early Career Scientist Session
        Early Career Scientist Presentation #3: Co-stimulatory Bispecific Engagers for the Treatment of Solid Tumors
        • Elaine Chen, PhD - Scientist, Translational Biology & Discovery, Rondo Therapeutics
        10:55am - 11:10am15 mins
        Early Career Scientist Session
        Early Career Scientist Presentation #4:
          11:10am - 11:30am20 mins
          Early Career Scientist Session
          Mid-Career Scientist Career Perspectives, Lessons Learned
          • James Ernst, Ph.D. - Vice President, Head of Protein Sciences and Technology Department, Xencor
          11:30am - 12:00pm30 mins
          Early Career Scientist Session
          Panel Discussion and Extended Q&A
          • James Ernst, Ph.D. - Vice President, Head of Protein Sciences and Technology Department, Xencor
          • Sarah Ives - Vice President, Biopharma, Triplebar Bio
          • Brandon DeKosky, Ph.D. - Assistant Professor of Chemical Engineering, MIT
          1:00pm - 1:15pm15 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Co-Chairs' Remarks: Quantitative Systems Pharmacology in Antibody Development
          • Karl Dane Wittrup, Ph.D. - C.P. Dubbs Professor in Chemical Engineering and Biological Engineering, Massachusetts Institute of Technology
          • Stephen Beers, PhD - Professor of Immunology and Immunotherapy, University of Southampton
          1:00pm - 1:15pm15 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Co-Chairs' Remarks: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
          • Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
          1:15pm - 1:45pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Advances in Understanding Cell Signaling in Immunotherapeutics
          • Douglas Lauffenburger, PhD - Ford Professor of Bioengineering, Massachusetts Institute of Technology
          1:15pm - 1:45pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Antibody Therapeutics: Riding the Pendulum of Innovation
          • Lazar Bojic, Ph.D. - Vice President of Investor Network, Curie.Bio
          1:45pm - 2:15pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Mathematical Modeling of Response to Immunotherapy in Pancreatic Ductal Adenocarcinoma
          • Daniel Bergman, Ph.D. - Postdoctoral Fellow, Johns Hopkins Medicine
          1:45pm - 2:15pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Protecting Innovations: IP Strategies for Antibody Therapeutics in a Competitive Market
          • Robin Silva - Consulting Patent Attorney, Xencor
          2:15pm - 2:45pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Designing Clinically Effective Antibody Drug Conjugates in Solid Tumors Using Quantitative Systems Pharmacology
          • Greg Thurber, Ph.D. - Assistant Professor, Chemical and Biomedical Engineering, University of Michigan
          2:15pm - 2:45pm30 mins
          Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
          Investing in Antibody-based Therapeutics
          • Sarah Hymowitz - Partner, The Column Group
          2:45pm - 3:15pm30 mins
          Workshop 1: Quantitative Systems Pharmacology in Antibody Development
          Networking Refreshment Break
            2:45pm - 3:15pm30 mins
            Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
            Networking Refreshment Break
              3:15pm - 3:45pm30 mins
              Workshop 1: Quantitative Systems Pharmacology in Antibody Development
              Bridging the In Vitro to In Vivo Gap for T-cell Engagers Using QSP Modeling
              • David Flowers, Ph.D. - Director, ABS, Certara
              3:15pm - 3:45pm30 mins
              Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
              Tackling the Impossible Task of Project Selection in An Early Stage Biotech Startup
              • Alexey Lugovskoy, Ph.D. - President and CEO, Diagonal Therapeutics
              3:45pm - 4:15pm30 mins
              Workshop 1: Quantitative Systems Pharmacology in Antibody Development
              Modeling Immunological Synapse Formation Initiated by Bispecific T cell Engagers: What, Why and How
              • Yanguang Cao, PhD - Associate Professor, University of North Carolina at Chapel Hill
              3:45pm - 4:15pm30 mins
              Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
              Carving out a Path to Differentiation in a Crowded Therapeutics Market
              • Shelley Force Aldred, Ph.D. - CEO, Rondo Therapeutics
              4:15pm - 4:45pm30 mins
              Workshop 1: Quantitative Systems Pharmacology in Antibody Development
              Comparison of Cancer-targeting and Stromal-targeting Antibody Drug Conjugates Using Bystander QSP models
              • Ezgi Wood, PhD - Senior Research Investigator, QSP, Bristol Myers Squibb
              4:15pm - 4:45pm30 mins
              Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
              Panel Discussion
              • Jonathan Sockolosky, PhD - Senior Director, CSO Partner Team, Curie.Bio
              • Jennifer Cochran, Ph.D. - Professor and Department Chair of Bioengineering, Stanford University
              4:45pm - 5:00pm15 mins
              Workshop 1: Quantitative Systems Pharmacology in Antibody Development
              Concluding Remarks
                4:45pm - 5:00pm15 mins
                Workshop 2: Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
                Concluding Remarks
                  5:00pm - 5:05pm5 mins
                  Close of Workshops and Training Course
                    Next MAIN CONFERENCE 12/6

                    * 活動內容有可能不事先告知作更動及調整。